FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996087674> ?p ?o ?g. }

• W1996087674 endingPage "269" @default.
• W1996087674 startingPage "261" @default.
• W1996087674 abstract "This phase II study was designed to assess the activity and tolerability of the carboplatin-paclitaxel combination, given without routine growth factor support to previously untreated patients with stage IIIB and IV non-small cell lung cancer.Sixty patients (15 stage IIIb and 45 stage IV) received paclitaxel 225 mg/ml on day 1, followed by carboplatin AUC 6 mg/ml per minute (Calvert formula) every 3 weeks. Paclitaxel was administered as a 3-h intravenous infusion followed by carboplatin over 30 min, on completion of paclitaxel administration.The combination showed a good safety profile with Grade 4 neutropenia occurring in 31% of patients without any serious infectious episodes requiring hospitalization. Moderate to severe anemia and thrombocytopenia seldom occurred. Sensorimotor peripheral neuropathy (Grade 2-3) and myalgia (Grade 3-4) were documented in 34 and 20% of the patients, respectively. Among 59 evaluable patients, there was one complete response and 26 partial responses for an overall response rate of 46% (95% C.I.: 34-59%). With a minimum follow-up duration of 16.5 months, the median overall survival time is 52 weeks and the 1-year survival rate is 50%. Median duration of response is 20 weeks (range: 4-52) and progression-free survival is 22 weeks (range: 5-77).In advanced NSCLC, the combination carboplatin-paclitaxel at doses of AUC 6 mg/ml per minute and 225 mg/ml every 3 weeks, is both active and relatively well-tolerated." @default.
• W1996087674 created "2016-06-24" @default.
• W1996087674 creator A5001428569 @default.
• W1996087674 creator A5008403882 @default.
• W1996087674 creator A5009256008 @default.
• W1996087674 creator A5026459926 @default.
• W1996087674 creator A5028773984 @default.
• W1996087674 creator A5029935476 @default.
• W1996087674 creator A5030661498 @default.
• W1996087674 creator A5034509029 @default.
• W1996087674 creator A5039473137 @default.
• W1996087674 creator A5056035743 @default.
• W1996087674 creator A5072948892 @default.
• W1996087674 creator A5091041625 @default.
• W1996087674 date "2001-11-01" @default.
• W1996087674 modified "2023-10-16" @default.
• W1996087674 title "Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer" @default.
• W1996087674 cites W1749876465 @default.
• W1996087674 cites W1755983531 @default.
• W1996087674 cites W1790560776 @default.
• W1996087674 cites W1842046266 @default.
• W1996087674 cites W1868450210 @default.
• W1996087674 cites W1909306097 @default.
• W1996087674 cites W1933707312 @default.
• W1996087674 cites W1934698255 @default.
• W1996087674 cites W1961110209 @default.
• W1996087674 cites W1975081329 @default.
• W1996087674 cites W2011447881 @default.
• W1996087674 cites W2034009362 @default.
• W1996087674 cites W2057157978 @default.
• W1996087674 cites W2061459572 @default.
• W1996087674 cites W2077169776 @default.
• W1996087674 cites W2089131647 @default.
• W1996087674 cites W2102551452 @default.
• W1996087674 cites W2116996913 @default.
• W1996087674 cites W2147766528 @default.
• W1996087674 cites W2169274051 @default.
• W1996087674 cites W2243915795 @default.
• W1996087674 cites W3041047318 @default.
• W1996087674 cites W4239714259 @default.
• W1996087674 doi "https://doi.org/10.1016/s0169-5002(01)00238-0" @default.
• W1996087674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11679185" @default.
• W1996087674 hasPublicationYear "2001" @default.
• W1996087674 type Work @default.
• W1996087674 sameAs 1996087674 @default.
• W1996087674 citedByCount "5" @default.
• W1996087674 countsByYear W19960876742018 @default.
• W1996087674 crossrefType "journal-article" @default.
• W1996087674 hasAuthorship W1996087674A5001428569 @default.
• W1996087674 hasAuthorship W1996087674A5008403882 @default.
• W1996087674 hasAuthorship W1996087674A5009256008 @default.
• W1996087674 hasAuthorship W1996087674A5026459926 @default.
• W1996087674 hasAuthorship W1996087674A5028773984 @default.
• W1996087674 hasAuthorship W1996087674A5029935476 @default.
• W1996087674 hasAuthorship W1996087674A5030661498 @default.
• W1996087674 hasAuthorship W1996087674A5034509029 @default.
• W1996087674 hasAuthorship W1996087674A5039473137 @default.
• W1996087674 hasAuthorship W1996087674A5056035743 @default.
• W1996087674 hasAuthorship W1996087674A5072948892 @default.
• W1996087674 hasAuthorship W1996087674A5091041625 @default.
• W1996087674 hasConcept C126322002 @default.
• W1996087674 hasConcept C141071460 @default.
• W1996087674 hasConcept C197934379 @default.
• W1996087674 hasConcept C2776256026 @default.
• W1996087674 hasConcept C2776283816 @default.
• W1996087674 hasConcept C2776694085 @default.
• W1996087674 hasConcept C2777063308 @default.
• W1996087674 hasConcept C2777292972 @default.
• W1996087674 hasConcept C2778239845 @default.
• W1996087674 hasConcept C2778248108 @default.
• W1996087674 hasConcept C2778375690 @default.
• W1996087674 hasConcept C2781451048 @default.
• W1996087674 hasConcept C31760486 @default.
• W1996087674 hasConcept C71924100 @default.
• W1996087674 hasConcept C90924648 @default.
• W1996087674 hasConceptScore W1996087674C126322002 @default.
• W1996087674 hasConceptScore W1996087674C141071460 @default.
• W1996087674 hasConceptScore W1996087674C197934379 @default.
• W1996087674 hasConceptScore W1996087674C2776256026 @default.
• W1996087674 hasConceptScore W1996087674C2776283816 @default.
• W1996087674 hasConceptScore W1996087674C2776694085 @default.
• W1996087674 hasConceptScore W1996087674C2777063308 @default.
• W1996087674 hasConceptScore W1996087674C2777292972 @default.
• W1996087674 hasConceptScore W1996087674C2778239845 @default.
• W1996087674 hasConceptScore W1996087674C2778248108 @default.
• W1996087674 hasConceptScore W1996087674C2778375690 @default.
• W1996087674 hasConceptScore W1996087674C2781451048 @default.
• W1996087674 hasConceptScore W1996087674C31760486 @default.
• W1996087674 hasConceptScore W1996087674C71924100 @default.
• W1996087674 hasConceptScore W1996087674C90924648 @default.
• W1996087674 hasIssue "2" @default.
• W1996087674 hasLocation W19960876741 @default.
• W1996087674 hasLocation W19960876742 @default.
• W1996087674 hasOpenAccess W1996087674 @default.
• W1996087674 hasPrimaryLocation W19960876741 @default.
• W1996087674 hasRelatedWork W1923927923 @default.
• W1996087674 hasRelatedWork W1983784941 @default.
• W1996087674 hasRelatedWork W1996087674 @default.

• next